Phase 1b Dose-finding Study of Venetoclax With Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

• Alessandra Petrillo,
• Andrew Ip,
• Alexandra Della Pia,
• Sarvainder Gill,
• Joshua Zenreich,
• Martin Gutierrez,
• Ann McNeill,
• Tatyana Feldman,
• Lori A. Leslie,
• Andre Goy

Affiliations

Alessandra Petrillo

1 Hackensack University Medical Center, Hackensack, NJ, USA

Andrew Ip

1 Hackensack University Medical Center, Hackensack, NJ, USA

Alexandra Della Pia

1 Hackensack University Medical Center, Hackensack, NJ, USA

Sarvainder Gill

1 Hackensack University Medical Center, Hackensack, NJ, USA

Joshua Zenreich

3 John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA

Martin Gutierrez

1 Hackensack University Medical Center, Hackensack, NJ, USA

Ann McNeill

3 John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA

Tatyana Feldman

1 Hackensack University Medical Center, Hackensack, NJ, USA

Lori A. Leslie

1 Hackensack University Medical Center, Hackensack, NJ, USA

Andre Goy

1 Hackensack University Medical Center, Hackensack, NJ, USA